Speakers

Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 5th mRNA Analytical Development & Quality Control.

James Shu

Vice President - Analytical Science
AboGen Inc.

Yurong Guo

Senior Director, Analytical Development
Arcturus Therapeutics

Bohdan Andreiuk

Senior Scientist - New Modality Preformulation & Lipid Nanoparticle formulation
AstraZeneca

Zack Zhang

Director - Analytical Development
Beam Therapeutics Inc.

Andreas Czech

Director Molecular Biology, Analytical Development
BioNTech

Atsuko Sakurai-Sangria

Director - Chemistry, Manufacturing, & Controls
Centivax

Stefan Heinz

Director - Analytical Science & Strategy
CureVac SE

Wayne Doyle

Head of Scientific Platforms & Strategy
Eclipse Bioinnovations

Faisal Ansari

QC Specialist & Data Analyst
Genetech Biotech

Jean-Francois Dierick

Strategic Analytical Validation & Lifecycle Lead
GlaxoSmithKline

Diana Posadas

director
GreenLight BioSciences

Yun-Ting Kao

Senior Scientist
Immunomic Therapeutics, Inc

Melanie Carroll

Quality Control Manager
Inventprise

Brendan Darby

Ahmed Al Azzam

Postdoctoral Research Fellow
Massachusetts College of Pharmacy and Health Sciences

Charles Kline

Associate Vice President - Regulatory Affairs & Chemistry Manufacturing Controls
Merck & Co

Salette Martinez

Associate Director - Analytical Development
nChroma Bio

Mark Lowenthal

Amanda Green

Associate Director - Quality Assurance
Orna Therapeutics

Kari Efferen

Senior Director & Head of Analytical Development
Pfizer

Samuel Valentin

Senior Manager - Strategic Sourcing & Vendor Management
Takeda Pharmaceutical

Elisabeth Boucher

Associate Director, Analytical Development
Tessera Therapeutics

Benjamin Hall

Associate Director
Tessera Therapeutics

Diane McCarthy

Vice President - Global Biologics
U.S. Pharmacopeia

Explore the Agenda

Dive into cutting-edge mRNA ADQC, that are both phase-appropriate and aligned with early to late stage settings.

View Presentations & Speakers

Partner With Us

Showcase your technologies and services to decision-makers actively seeking and driving next-generation mRNA therapeutics.

Explore Sponsorship Options

Join mRNA Leaders

Be part of the only forum uniting leading pharma, biotech, academia and regulatory experts